AH Calvert
- Otorhinolaryngology top 10%
-
- Cancer Treatment and Pharmacology 4
-
- Quinazolinone synthesis and applications 6
- Synthesis and Characterization of Heterocyclic Compounds 4
-
- Biochemical and Molecular Research 4
-
- Health, Medicine and Society 7
- Aging, Elder Care, and Social Issues 7
-
- Hermeneutics and Narrative Identity 7
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- KR HarrapAnn L. JackmanDR NewellL A PriceGraham M. F. BissetLeslie R. HughesDavid R. NewellBrigid M. O'Connor
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Medicinal Chemistry (3 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomItalyCanada
In The Last Decade
AH Calvert
29 papers receiving 315 citations
Peers
Comparison fields: 5 of 63
- Otorhinolaryngology 28
- Oncology 161
- Organic Chemistry 86
- Molecular Biology 171
- Genetics 21
Countries citing papers authored by AH Calvert
This map shows the geographic impact of AH Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AH Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AH Calvert more than expected).
Fields of papers citing papers by AH Calvert
This network shows the impact of papers produced by AH Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AH Calvert. The network helps show where AH Calvert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside AH Calvert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era | 2002 | 1 |
| 2 | Structural and thermodynamic validation of inactive cdk2 as a template for structure-based drug design | 2001 | 1 |
| 3 | Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E | 2000 | 7 |
| 4 | A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors | 1999 | 7 |
| 5 | 1995 | 27 | |
| 6 | 1993 | 4 | |
| 7 | 1992 | 25 | |
| 8 | 1990 | 16 | |
| 9 | PHASE-I STUDY OF THE ANTHRAPYRAZOLE CI-941 WITH PHARMACOKINETICALLY GUIDED DOSE ESCALATION | 1988 | 1 |
| 10 | A PHASE-I HIGH-DOSE ESCALATION STUDY OF CARBOPLATIN | 1987 | 3 |
| 11 | PHARMACOLOGICAL STUDIES WITH THE ANTHRAPYRAZOLE CI 941 - A NEW DNA COMPLEXING DRUG | 1986 | 2 |
| 12 | 1986 | 3 | |
| 13 | PRECLINICAL AND CLINICAL-STUDIES WITH N-2, N-4, N-6-TRIHYDROXYMETHYL, N-2, N-4, N-6-TRIMETHYLMELAMINE, AN ALTERNATIVE TO PENTAMETHYLMELAMINE | 1985 | 1 |
| 14 | REPORT ON THE PHASE I TRIAL OF N-2, N-4, N-6-TRIHYDROXYMETHYL-N-2, N-4, N-6-TRIMETHYLMELAMINE (TRIMELAMOL) | 1985 | 1 |
| 15 | PHASE-I CLINICAL-TRIAL OF CB3717 ((N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID) | 1984 | 0 |
| 16 | TOXICITY AND PHARMACOKINETIC STUDIES WITH CB3717 | 1983 | 1 |
| 17 | PHARMACOKINETIC STUDIES IN HUMANS WITH CB3717 (N-(4-(2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID) | 1983 | 1 |
| 18 | 2-AMINO-4-HYDROXY QUINAZOLINES WITH DUAL METABOLIC LOCI IN METHOTREXATE RESISTANT CELLS | 1979 | 2 |
| 19 | IMPROVED RESULTS IN COMBINATION CHEMOTHERAPY OF HEAD AND NECK CANCER | 1977 | 2 |
| 20 | 1975 | 41 |
About AH Calvert
AH Calvert is a scholar working on Philosophy, Oncology, Organic Chemistry, General Health Professions and Molecular Biology, having authored 32 papers that have together received 336 indexed citations. Recurring topics across this work include Health, Medicine and Society (7 papers), Hermeneutics and Narrative Identity (7 papers), Aging, Elder Care, and Social Issues (7 papers), Quinazolinone synthesis and applications (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers), Biochemical and Molecular Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Otorhinolaryngology (28 citations), Oncology (161 citations), Organic Chemistry (86 citations), Molecular Biology (171 citations) and Genetics (21 citations). AH Calvert has collaborated with scholars based in United Kingdom, Italy and Canada. Frequent co-authors include KR Harrap, Ann L. Jackman, DR Newell, L A Price, Graham M. F. Bisset, Leslie R. Hughes, David R. Newell, Brigid M. O'Connor, Peter R. Marsham and Jane Endicott. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, European Journal of Cancer, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.